Two highly prevalent pulmonary diseases, lung cancer and chronic obstructive lung disease
(COPD), show both sex and gender differences in their presentations and outcomes. Sex …

Lung cancer is becoming increasingly common in women and in the United States accounts
for more female cancer deaths annually than breast cancer. Many epidemiological studies …

Experimental and population-based evidence has been steadily accumulating that steroid
hormones are fundamentally involved in the biology of the lung. Both estrogen and …

The incidence of lung cancer in females is increasing, in contrast to that seen in males. In
addition, the proportion of lung cancer cases in women attributable to smoking is …

Lung cancer is the leading cause of cancer death in US and represents a major public
health burden. Epidemiologic data have suggested that lung cancer in women may possess …

Accumulating evidence suggests that gender impacts the incidence, susceptibility and
severity of several lung diseases. Gender also influences lung development and physiology …

Lung cancer has long been thought of as a cancer that mainly affects men, but over the past
several decades, because of the high increase in tobacco use by women, there has been a …

Accumulating evidence suggests that gender affects the incidence, susceptibility and
severity of several lung diseases. Gender also influences lung development and physiology …

Gender differences in lung disease and cancer are well-established. We reported estrogenic
transcriptional responses in lung adenocarcinoma cells from females but not males despite …

The role of estrogens in the increased risk of lung adenocarcinoma in women remains
uncertain. We reported that lung adenocarcinoma cell lines from female, but not male …